当前位置:首页 - 行情中心 - 凯普生物(300639) - 财务分析 - 现金流量表

凯普生物

(300639)

  

流通市值:40.40亿  总市值:41.44亿
流通股本:6.30亿   总股本:6.47亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金407,700,604.43189,409,150.321,078,014,877.59693,484,670.77
  收到的税费返还44,035.789,330.828,881.42121,212.14
  收到其他与经营活动有关的现金13,258,501.7111,864,920.7841,254,332.0720,518,823.64
  经营活动现金流入小计421,003,141.92201,283,401.921,119,278,091.08714,124,706.55
  购买商品、接受劳务支付的现金75,316,836.8831,482,657.48161,336,433.12139,627,738.3
  支付给职工以及为职工支付的现金149,240,627.2980,028,333.19322,961,488.93245,123,058.88
  支付的各项税费37,662,198.0915,192,312.9455,623,310.0337,743,624.19
  支付其他与经营活动有关的现金88,069,966.7349,629,272.86237,748,112.19170,419,884.97
  经营活动现金流出小计350,289,628.99176,332,576.47777,669,344.27592,914,306.34
  经营活动产生的现金流量净额70,713,512.9324,950,825.45341,608,746.81121,210,400.21
二、投资活动产生的现金流量:
  收回投资收到的现金403,000,000172,000,000745,342,727.59658,000,102.76
  取得投资收益收到的现金1,975,046.61427,510.522,245,585.831,887,967.82
  处置固定资产、无形资产和其他长期资产收回的现金净额718,289717,0871,636,578.83605,350
  收到的其他与投资活动有关的现金422,690,454.178,835,32840,000,000-
  投资活动现金流入小计828,383,789.71251,979,925.52789,224,892.25660,493,420.58
  购建固定资产、无形资产和其他长期资产支付的现金90,588,977.2318,144,090.3692,394,164.8348,444,840.57
  投资支付的现金422,568,746.25202,694,787.92761,242,882.19631,500,000
  取得子公司及其他营业单位支付的现金---5,700,000
  支付其他与投资活动有关的现金444,454,953.69350,990,716.7678,835,328-
  投资活动现金流出小计957,612,677.17571,829,595.04932,472,375.02685,644,840.57
  投资活动产生的现金流量净额-129,228,887.46-319,849,669.52-143,247,482.77-25,151,419.99
三、筹资活动产生的现金流量:
  吸收投资收到的现金--8,000,0008,000,000
  其中:子公司吸收少数股东投资收到的现金--8,000,0008,000,000
  取得借款收到的现金--46,000,00046,000,000
  收到其他与筹资活动有关的现金--5,812,675.91-
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--59,812,675.9154,000,000
  偿还债务支付的现金4,012,000-45,059,79223,035,192
  分配股利、利润或偿付利息支付的现金879,317.52435,472.514,884,299.563,032,190.39
  其中:子公司支付给少数股东的股利、利润--1,388,618.9-
  支付其他与筹资活动有关的现金19,090,554.8611,835,806.37152,984,126.29104,708,934.93
  筹资活动现金流出小计23,981,872.3812,271,278.88202,928,217.85130,776,317.32
  筹资活动产生的现金流量净额-23,981,872.38-12,271,278.88-143,115,541.94-76,776,317.32
四、汇率变动对现金及现金等价物的影响-18,357,360.61-11,941,768.92-9,394,780.053,388,635.5
五、现金及现金等价物净增加额-100,854,607.52-319,111,891.8745,850,942.0522,671,298.4
  加:期初现金及现金等价物余额707,966,718.14707,988,956.11662,115,776.09662,115,776.09
  期末现金及现金等价物余额607,112,110.62388,877,064.24707,966,718.14684,787,074.49
补充资料:
  净利润25,393,331.37--182,280,400.25-
  资产减值准备-30,008,086.72-62,269,395.63-
  固定资产和投资性房地产折旧68,571,438.43-140,881,227.62-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧68,571,438.43-140,881,227.62-
  无形资产摊销4,207,724.86-12,850,546.28-
  长期待摊费用摊销4,504,142.84-17,824,727.67-
  处置固定资产、无形资产和其他长期资产的损失229,799.78--434,231.78-
  固定资产报废损失179,317.17-460,897.52-
  公允价值变动损失-10,101,818.35--4,973,032.53-
  财务费用-35,886,809.23-3,183,250.62-
  投资损失338,610.96-1,125,109.6-
  递延所得税4,054,393.74-351,826.49-
  其中:递延所得税资产减少6,660,996.03-19,550,575.54-
    递延所得税负债增加-2,606,602.29--19,198,749.05-
  存货的减少-1,231,928.68-8,368,583.97-
  经营性应收项目的减少78,172,807.72-337,928,885.4-
  经营性应付项目的增加-38,055,433.05--60,501,918.98-
  其他-2,799,757.85--1,139,339.49-
  现金的期末余额607,112,110.62-707,966,718.14-
  减:现金的期初余额707,966,718.14-662,115,776.09-
  现金及现金等价物的净增加额-100,854,607.52-45,850,942.05-
公告日期2026-08-152026-04-292026-04-292025-10-29
审计意见(境内)标准无保留意见
TOP↑